Xenglu Met 5/500mg Tablet – Gentle Starter Empagliflozin + Metformin XR
Xenglu Met 5/500mg Tablet – Gentle Starter Empagliflozin + Metformin XR
Xenglu Met 5/500mg Tablet – Gentle Starter Empagliflozin + Metformin XR
Description
Xenglu Met 5/500mg Tablet – Mild Dual Therapy with Heart & Kidney Protection from Day One
Xenglu Met 5/500mg Tablet combines empagliflozin 5mg (SGLT2 inhibitor) with metformin extended-release 500mg in a single, easy-to-tolerate once-daily tablet. This gentle-strength combination is perfect for patients newly starting dual therapy or those sensitive to higher metformin doses delivers steady blood sugar reduction while adding clinically proven cardiovascular protection, slows diabetic kidney disease progression, and offers modest weight loss and blood pressure lowering. The low-dose, extended-release formula minimizes stomach upset, making it an excellent first-step combination for long-term diabetes management
